actinium has been researched along with Metastase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, CK; Kaur, K; Mittal, BR; Parmar, M; Sood, A; Vadi, SK; Vatsa, R | 1 |
| Gómez de Iturriaga, A; Mínguez Gabiña, P; Mínguez, R; Rodeño, E; Roeske, JC | 1 |
| Beheshti, A; Bruchertseifer, F; D'Alessandria, C; Eiber, M; Feuerecker, B; Gafita, A; Gschwend, JE; Heck, M; Knorr, K; Kratochwil, C; Morgenstern, A; Pickhard, A; Retz, M; Seidl, C; Tauber, R; Weber, WA | 1 |
| Bruchertseifer, F; Custers, JAE; Gerritsen, WR; Haberkorn, U; Janssen, MJR; Kratochwil, C; Kroeze, LI; Looijen-Salamon, MG; Mehra, N; Morgenstern, A; Nagarajah, J; Slootbeek, PHJ; van der Doelen, MJ; van Oort, IM | 1 |
| Bal, C; Ballal, S; Dwivedi, SN; Sahoo, RK; Tripathi, M; Yadav, MP | 1 |
| Aranda-Lara, L; Azorín-Vega, E; Nava-Cabrera, M; Oros-Pantoja, R | 1 |
| McDevitt, MR; Sgouros, G; Sofou, S | 1 |
| Bednarz, B; Lee, D; Li, M; Schultz, MK | 1 |
| Lin, HY; McDevitt, MR; Scheinberg, DA; Sgouros, G; Sofou, S; Thomas, JL | 1 |
| Chang, MY; Seideman, J; Sofou, S | 1 |
2 review(s) available for actinium and Metastase
| Article | Year |
|---|---|
Topics: Actinium; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Theranostic Nanomedicine; Treatment Outcome | 2021 |
Targeted and Nontargeted α-Particle Therapies.
Topics: Actinium; Alpha Particles; Animals; Cell Survival; Clinical Trials as Topic; Drug Carriers; Humans; Kinetics; Leukemia; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radium | 2018 |
8 other study(ies) available for actinium and Metastase
| Article | Year |
|---|---|
225Ac-PSMA-617 Radioligand Posttherapy Imaging in Metastatic Castrate-Resistant Prostate Cancer Patient Using 3 Photopeaks.
Topics: Actinium; Alpha Particles; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant | 2020 |
Microdosimetry-based determination of tumour control probability curves for treatments with
Topics: Actinium; Antigens, Surface; Glutamate Carboxypeptidase II; Humans; Male; Monte Carlo Method; Neoplasm Metastasis; Probability; Prostatic Neoplasms, Castration-Resistant; Radiometry; Radiotherapy Dosage | 2020 |
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Topics: Actinium; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Xerostomia | 2021 |
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with
Topics: Actinium; Humans; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2021 |
Comparison between
Topics: Actinium; Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Humans; Lutetium; Mice, Nude; Neoplasm Metastasis; Radioisotopes; Radiometry | 2021 |
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes | 2018 |
Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Liposomes; Microscopy, Electron; Neoplasm Metastasis; Radioisotopes | 2004 |
Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases.
Topics: Actinium; Alpha Particles; Animals; Buffers; Cell Line, Tumor; Drug Stability; Heating; Humans; Immunoconjugates; Ionophores; Lipid Bilayers; Liposomes; Mice; Neoplasm Metastasis; Particle Size; Permeability; Polyethylene Glycols; Temperature; Time Factors | 2008 |